Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma
NCT00492076
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Asthma
Interventions
BIOLOGICAL:
Pangramin Plus D. pteronyssinus 100%
Sponsor
ALK-Abelló A/S